InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 330535

Monday, 06/03/2019 1:42:26 PM

Monday, June 03, 2019 1:42:26 PM

Post# of 345969
Now all it takes is a slight of hand connection from Ronin - John Springs Stafford to a Sumitomo affiliation etc and this little heist of an IP transfer comes to a screeching halt ...no worries, Stafford or Ronin is used to settling with SEC with no admission of guilt and will gladly pay a fine


_____

Current Assignee: Biothera Inc


DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

....the invention may also be carried out with complement activating immune suppression-relieving agents. One example may be bavituximab.

https://patents.google.com/patent/US10111901
___

April 13, 2017 published
April 19, 2017 assigned to Ronin...I mean Biothera!

July 10, 2035 and that is a long time

Inventor Nandita BoseKeith GORDENAnissa S H. ChanSteven LEONARDOJeremy GRAFFXiaohong QiuTakashi KANGASKathryn A. FRASERAdria BYKOWSKI JONASNadine OTTOSONRoss Fulton Current Assignee Biothera Inc
Worldwide applications
2015 CN WO JP EP 2016 US 2018 US
Application US15/386,887 events
2014-07-10
Priority to US201462022754P
2014-11-06
Priority to US201462076094P
2015-02-13
Priority to US201562115895P
2015-04-20
Priority to US201562149892P
2015-07-10
Priority to PCT/US2015/039977
2016-12-21
Priority to US15/386,887
2016-12-21
Application filed by Biothera Inc
2017-04-13
Publication of US20170100425A1
2017-04-19
Assigned to BIOTHERA, INC.
2018-10-30
Application granted
2018-10-30
Publication of US10111901B2
2019-06-03
Application status is Active
2035-07-10
Anticipated expiration


https://patents.google.com/patent/US10111901
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News